Optical Genome Mapping Market to Reach $1.5 Billion by 2035 with a CAGR of 23.9%
Optical genome mapping market is driven by the increasing demand for advanced genomic analysis technologies, rising prevalence of genetic disorders and cancer, and growing adoption of precision medicine and personalized healthcare solutions. The technology is gaining significant traction in structural variation detection, genome assembly, microbial strain typing, and haplotype phasing due to its ability to provide high-resolution genome analysis beyond traditional sequencing methods. In addition, increasing investments in genomic research, expanding biotechnology and pharmaceutical R&D activities, and the growing use of optical genome mapping in clinical diagnostics and academic research are further accelerating market growth globally.
Browse the full report description of “Optical Genome Mapping Market Size, Share & Trends Analysis Report By Offerings (Consumables, Instruments, Services, and Software), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, and Others), And By End Users (Research & Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories And Others (CRO)), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/optical-genome-mapping-market
Optical genome mapping (OGM) diagnostic assays segment is expected to account for a major market share in 2026
Optical genome mapping (OGM) diagnostic assays are expected to hold a major market share in 2026, primarily due to the increasing adoption of advanced cytogenetic technologies for detecting structural genomic variations in oncology and genetic disorder diagnostics. These assays provide high-resolution genome analysis capabilities that improve detection of chromosomal abnormalities, gene rearrangements, and complex structural variants compared to conventional cytogenetic methods. The publication of expert recommendations by the International Consortium for Optical Genome Mapping supporting integration of OGM into diagnostic workflows for blood cancers highlights the growing clinical acceptance of optical genome mapping technologies as a standard-of-care cytogenetic assay. Rising demand for precision oncology diagnostics and advanced genomic testing workflows is expected to significantly contribute to the growth of the OGM diagnostic assays segment.
Clinical optical genome mapping platforms segment is expected to account for a major market share in 2026
Clinical optical genome mapping platforms are expected to hold a major market share in 2026 owing to the expanding use of genome analysis technologies across hematologic malignancies, constitutional genetics, and cell and gene therapy applications. These platforms are increasingly being adopted by clinical laboratories and research institutions for comprehensive genomic characterization and advanced molecular diagnostics. The Q1 2026 business update from Bionano Genomics highlighted growing adoption of its optical genome mapping and VIA software platforms, alongside increasing peer-reviewed publications and stronger reimbursement support through new CPT codes effective January 2026. Expanding reimbursement coverage, increasing clinical validation, and rising integration of genomic technologies into precision medicine workflows are expected to further accelerate the growth of the clinical optical genome mapping platforms segment.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404